CDC launches official influenza app for health professionals
ATLANTA — The Centers for Disease Control and Prevention on Monday announced the launch of its CDC Influenza application for clinicians and other healthcare professionals on the Apple platform. The app makes it easy to access CDC’s latest recommendations and influenza activity updates on an iPad, iPhone or iPod Touch, the agency stated.
An Android support will be added in a future update, CDC noted.
Content updates automatically with an Internet connection. Users will be able to view updated information on national flu activity; find influenza vaccination recommendations endorsed by CDC and the Advisory Committee on Immunization Practices; obtain information on diagnosis and treatment of influenza, including antiviral treatment recommendations by CDC and the ACIP; obtain information on laboratory testing for influenza; find CDC recommendations on influenza infection control; view videos of CDC subject matter experts discussing influenza topics; and order official CDC designed print products for posting in the workplace or distributing to patients.
FOR MORE COVERAGE OF THE FLU EPIDEMIC CLICK HERE
Harvard Men’s Health Watch recommends topical analgesics for acute joint pain
BOSTON — Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men’s Health Watch.
"Topical pain relievers can be very helpful for the more superficial joints like the knees, ankles, feet, elbows and hands," stated Rosalyn Nguyen, a clinical instructor in physical medicine and rehabilitation at Harvard Medical School. "In those areas, the medication can penetrate closer to the joint."
The source of pain usually determines if a topical pain reliever is appropriate. For a localized problem with just one joint causing the pain, there’s no need for medication to travel throughout the body, Nguyen noted. A topical analgesic isn’t that helpful when pain emanates across an extended area, like the lower back.
Nguyen recommended trying a prescription topical analgesic, such as diclofenac gel. However, for patients looking for over-the-counter pain relief, Nguyen recommended Icy Hot or Bengay, which temporarily masks pain with a sensation of coolness or heat.
Chattem acquires Rolaids brand from McNeil
PARIS — Sanofi on Monday announced that its U.S. Consumer Healthcare Division Chattem, completed the acquisition of the worldwide rights to the Rolaids brand from McNeil Consumer Healthcare for an undisclosed amount.
"The addition of Rolaids represents a rare opportunity to obtain an iconic brand that we believe will respond positively to our proven approach of growing brands through innovation and advertising," stated Zan Guerry, CEO, Chattem. "We are primed to leverage the Rolaids market opportunity to drive incremental growth and take the brand to a new level."
Rolaids was first introduced in 1954. Chattem will re-launch Rolaids and expects the product to be available at retailers within a year.
"This acquisition is consistent with our long-term strategy, which includes growing our consumer healthcare offering as part of a broader diversification strategy," stated Anne Whitaker, president, North America Pharmaceuticals, Sanofi. "Chattem has a proven track record of successful acquisitions and integrations and the addition of Rolaids, an enduring brand with a deep heritage, further diversifies the company’s portfolio."